Pharma Tech

Sublingual semaglutide offered to UK practices despite Novo Nordisk concerns

Jul 31, 2026, 10:57 AM

Read Full Article → Sublingual semaglutide offered to UK practices despite Novo Nordisk concerns

Translate article text

Choose a language and wait for the translated text.

Sublingual semaglutide, which does not hold marketing authorisation, is touted to minimise gastric issues.